Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOMAR GROUP A/S - Group

Quicksearch from your own companies XBRLDenmarkIFRS Analyst: XBRLDenmarkIFRS

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.8% 0.8% 1.3% 1.3% 1.4% 1.0% 5.1% 4.9%   Credit score (0-100)   94 93 79 77 78 85 17 18   Credit rating   A A BBB BBB BBB A BB BB   Credit limit (mDKK)   283.6 310.2 42.5 40.3 34.9 239.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   10,328 11,180 11,649 13,300 17,861 17,878 17,878 17,878   Gross profit   1,279 1,482 1,464 892 1,037 1,259 0.0 0.0   EBITDA   608 709 642 889 957 1,214 0.0 0.0   EBIT   608 709 642 540 602 860 0.0 0.0   Pre-tax profit (PTP)   573.5 675.9 538.3 539.5 709.3 654.2 0.0 0.0   Net earnings   410.1 540.6 396.2 397.8 555.5 483.5 0.0 0.0   Pre-tax profit without non-rec. items   574 676 538 539 709 654 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,291 1,745 1,625 1,683 1,743 1,716 0.0 0.0   Shareholders equity total   2,583 2,857 2,664 2,917 3,190 3,125 2,044 2,044   Interest-bearing liabilities   1,415 2,565 2,258 2,820 3,635 3,729 0.0 0.0   Balance sheet total (assets)   7,141 8,776 8,509 10,004 11,705 11,181 2,044 2,044   Net Debt   1,130 2,295 1,965 2,558 3,336 3,545 -659 -659     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   10,328 11,180 11,649 13,300 17,861 17,878 17,878 17,878   Net sales growth   3.7% 8.3% 4.2% 14.2% 34.3% 0.1% 0.0% 0.0%   Gross profit   1,279 1,482 1,464 892 1,037 1,259 0.0 0.0   Gross profit growth   4.2% 15.8% -1.2% -39.0% 16.2% 21.5% -100.0% 0.0%   Employees   0 0 0 1,463 1,589 1,613 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 8.6% 1.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,141 8,776 8,509 10,004 11,705 11,181 2,044 2,044   Balance sheet change%   13.4% 22.9% -3.0% 17.6% 17.0% -4.5% -81.7% 0.0%   Added value   608.4 708.8 641.8 889.4 952.1 1,214.4 0.0 0.0   Added value %   5.9% 6.3% 5.5% 6.7% 5.3% 6.8% 0.0% 0.0%   Investments   1,013 472 -254 -151 -133 -486 -1,716 0   Net sales trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   5.9% 6.3% 5.5% 6.7% 5.4% 6.8% 0.0% 0.0%   EBIT %   5.9% 6.3% 5.5% 4.1% 3.4% 4.8% 0.0% 0.0%   EBIT to gross profit (%)   47.6% 47.8% 43.9% 60.5% 58.1% 68.3% 0.0% 0.0%   Net Earnings %   4.0% 4.8% 3.4% 3.0% 3.1% 2.7% 0.0% 0.0%   Profit before depreciation and extraordinary items %   4.0% 4.8% 3.4% 5.6% 5.1% 4.7% 0.0% 0.0%   Pre tax profit less extraordinaries %   5.6% 6.0% 4.6% 4.1% 4.0% 3.7% 0.0% 0.0%   ROA %   9.2% 9.5% 7.2% 6.6% 8.0% 8.1% 0.0% 0.0%   ROI %   15.1% 15.5% 12.0% 11.4% 13.8% 13.6% 0.0% 0.0%   ROE %   16.2% 19.9% 14.4% 15.3% 21.1% 17.7% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   36.2% 32.6% 31.3% 29.2% 27.3% 28.0% 100.0% 100.0%   Relative indebtedness %   44.1% 52.9% 50.2% 53.3% 47.7% 45.1% 0.0% 0.0%   Relative net indebtedness %   41.4% 50.5% 47.7% 51.3% 46.0% 44.0% -3.7% -3.7%   Net int. bear. debt to EBITDA, %   185.8% 323.8% 306.2% 287.6% 348.5% 291.9% 0.0% 0.0%   Gearing %   54.8% 89.8% 84.7% 96.7% 113.9% 119.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 4.0% 3.4% 2.9% 5.1% 7.5% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.6 0.6 0.6 0.5 0.6 0.0 0.0   Current Ratio   1.1 0.9 0.9 0.9 0.9 0.9 0.0 0.0   Cash and cash equivalent   284.4 269.8 292.8 261.7 298.9 183.8 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   38.5% 40.4% 40.3% 43.0% 40.1% 38.6% 3.7% 3.7%   Net working capital   282.0 -452.7 -356.0 -779.0 -831.8 -721.2 0.0 0.0   Net working capital %   2.7% -4.0% -3.1% -5.9% -4.7% -4.0% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 9 11 11 0 0   Added value / employee   0 0 0 1 1 1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 1 1 1 0 0   EBIT / employee   0 0 0 0 0 1 0 0   Net earnings / employee   0 0 0 0 0 0 0 0